1. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. (21st September 2018) Authors: Rambau, Peter F; Vierkant, Robert A; Intermaggio, Maria P; Kelemen, Linda E; Goodman, Marc T; Herpel, Esther; Pharoah, Paul D; Kommoss, Stefan; Jimenez‐Linan, Mercedes; Karlan, Beth Y; Gentry‐Maharaj, Aleksandra; Menon, Usha; Polo, Susanna Hernando; Candido dos Reis, Francisco J; Doherty, Jennife... Journal: Journal of pathology Issue: Volume 4:Number 4(2018) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin. (22nd June 2018) Authors: Po, Joseph W; Roohullah, Aflah; Lynch, David; DeFazio, Anna; Harrison, Michelle; Harnett, Paul R; Kennedy, Catherine; de Souza, Paul; Becker, Therese M Journal: Journal of circulating biomarkers Issue: Volume 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. New therapeutic opportunities for low-grade serous ovarian cancer. Issue 5 (October 2021) Authors: Moujaber, Tania; Balleine, Rosemary L; Gao, Bo; Madsen, Ida; Harnett, Paul R; DeFazio, Anna Journal: Endocrine-related cancer Issue: Volume 28:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. New therapeutic opportunities for women with low-grade serous ovarian cancer. Issue 1 (11th November 2021) Authors: Moujaber, Tania; Balleine, Rosemary L; Gao, Bo; Madsen, Ida; Harnett, Paul R; DeFazio, Anna Journal: Endocrine-related cancer Issue: Volume 29:Issue 1(2022) Page Start: R1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Our Faustian pact with the digital world. Issue 2 (February 2017) Authors: McNeil, Catriona M; Harnett, Paul R Journal: Lancet oncology Issue: Volume 18:Issue 2(2017:Feb.) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas. Issue 4 (7th February 2022) Authors: Heinze, Karolin; Nazeran, Tayyebeh M; Lee, Sandra; Krämer, Pauline; Cairns, Evan S; Chiu, Derek S; Leung, Samuel CY; Kang, Eun Young; Meagher, Nicola S; Kennedy, Catherine J; Boros, Jessica; Kommoss, Friedrich; Vollert, Hans‐Walter; Heitz, Florian; du Bois, Andreas; Harter, Philipp; Grube, Marcel... Journal: Journal of pathology Issue: Volume 256:Issue 4(2022) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗